ZA932648B - Sythetic polypeptides - Google Patents

Sythetic polypeptides

Info

Publication number
ZA932648B
ZA932648B ZA932648A ZA932648A ZA932648B ZA 932648 B ZA932648 B ZA 932648B ZA 932648 A ZA932648 A ZA 932648A ZA 932648 A ZA932648 A ZA 932648A ZA 932648 B ZA932648 B ZA 932648B
Authority
ZA
South Africa
Prior art keywords
sythetic
polypeptides
sythetic polypeptides
Prior art date
Application number
ZA932648A
Other languages
English (en)
Inventor
Robert Vincent Fishleigh
Barry Robson
Roger Aston
Original Assignee
Proteus Molecular Design
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Molecular Design filed Critical Proteus Molecular Design
Publication of ZA932648B publication Critical patent/ZA932648B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA932648A 1992-04-16 1993-04-15 Sythetic polypeptides ZA932648B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208428A GB9208428D0 (en) 1992-04-16 1992-04-16 Synthetic polypeptides

Publications (1)

Publication Number Publication Date
ZA932648B true ZA932648B (en) 1994-10-15

Family

ID=10714175

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA932648A ZA932648B (en) 1992-04-16 1993-04-15 Sythetic polypeptides

Country Status (9)

Country Link
EP (1) EP0636145A1 (xx)
JP (1) JPH07505878A (xx)
KR (1) KR950700933A (xx)
CN (1) CN1082053A (xx)
AU (1) AU3960493A (xx)
CA (1) CA2118033A1 (xx)
GB (1) GB9208428D0 (xx)
WO (1) WO1993021218A1 (xx)
ZA (1) ZA932648B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
KR950702839A (ko) 1992-08-27 1995-08-23 스티븐 딕 레트로, 인버소-, 및 레트로- 인버소 합성 펩티드 유사체(retro-, inverso-, and retro-inverso synthetic peptide analogues)
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
FR2717081B1 (fr) * 1994-03-14 1996-06-21 Centre Nat Rech Scient Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro.
US5705522A (en) * 1995-09-15 1998-01-06 Compagnie De Developpement Aguettant S.A. Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
CN100366633C (zh) * 2006-04-18 2008-02-06 河北师范大学 棕点湍蛙抗病毒多肽及其在制药中的应用
JP2008173077A (ja) * 2007-01-22 2008-07-31 National Institute Of Advanced Industrial & Technology 膜タンパク質の発現を解析するモニタータンパク質

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
WO1989010416A1 (en) * 1988-04-20 1989-11-02 Trustees Of The University Of Pennsylvania PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS-1 gp160
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
GB9005829D0 (en) * 1990-03-15 1990-05-09 Proteus Biotech Ltd Synthetic polypeptides

Also Published As

Publication number Publication date
GB9208428D0 (en) 1992-06-03
JPH07505878A (ja) 1995-06-29
CN1082053A (zh) 1994-02-16
KR950700933A (ko) 1995-02-20
AU3960493A (en) 1993-11-18
EP0636145A1 (en) 1995-02-01
WO1993021218A1 (en) 1993-10-28
CA2118033A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
GB2269176B (en) Peptides
KR0128485B1 (en) Switch
SG44598A1 (en) Switch
GB9414833D0 (en) Polypeptide
ZA932648B (en) Sythetic polypeptides
GB9226065D0 (en) Peptides
TW406887U (en) Switch
GB9324013D0 (en) Polypeptides
ZW9093A1 (en) Synthetic polypeptides
ZA922067B (en) Chimaeric polypeptides
PL299367A1 (en) Linear peptides
ZA931299B (en) Novel peptides
GB9211668D0 (en) Peptide compounds
GB9218056D0 (en) Polypeptides
GB9213437D0 (en) Polypeptides
GB9219710D0 (en) Synthetic polypeptides
ZA935308B (en) Synthetic polypeptides
GB9218163D0 (en) Synthetic polypeptides
GB9214663D0 (en) Synthetic polypeptides
ZA935126B (en) Peptides
GB9210074D0 (en) Peptides
GB9226074D0 (en) Peptide
GB9324350D0 (en) Polypeptides
GB2265756B (en) Switch
ZA941064B (en) Novel polypeptides